AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2783580 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive-educative telephone program implemented by a cardiac rehabilitation nurse specialist
Number of subjects: 74
Study 2783580 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study 31724170 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-dense chemotherapy (administered every 2 weeks)
Number of subjects: 452
Study 31724170 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-dense chemotherapy with trastuzumab
Number of subjects: 452
Study 31724170 — intervention group
Group type: COMPARATOR
Intervention: Standard-interval chemotherapy (administered every 3 weeks)
Number of subjects: 452
Study 29998997 — intervention group
Group type: EXPERIMENTAL
Intervention: Yangyin Tiluo Decoction (YTD) for 4 weeks (200 mL of the decoction two times daily)
Number of subjects: 12
Study 29998997 — intervention group
Group type: COMPARATOR
Intervention: Healthy control (no intervention)
Number of subjects: 12
Study 28254383 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-expanding paclitaxel-eluting stent (PES) with a nominal diameter of 6mm
Number of subjects: 20
Study 28254383 — intervention group
Group type: COMPARATOR
Intervention: Self-expanding paclitaxel-eluting stent (PES) with a nominal diameter of 8mm
Number of subjects: 20
Study 26227019 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-h serum sample
Number of subjects: 29
Study 26227019 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-h serum measurement with GFR
Number of subjects: 29
Study 26227019 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-h serum isotope levels in Cohort 2
Number of subjects: 29
Study 26227019 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-h serum isotope levels in Cohort 2
Number of subjects: 29
Study 24257388 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam
Number of subjects: 96
Study 24257388 — intervention group
Group type: EXPERIMENTAL
Intervention: Video glasses
Number of subjects: 96
Study 24257388 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined (midazolam + video glasses)
Number of subjects: 96
Study 20843496 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail reminder group (letter plus CDC Influenza Vaccine Information Statement)
Number of subjects: 884
Study 20843496 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone reminder group (personal phone call with same information)
Number of subjects: 884
Study 20843496 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 884
Study 18396369 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib 120 mg
Number of subjects: 80
Study 18396369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 16330297 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (10 mg IM single injection)
Number of subjects: 236
Study 16330297 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (7.5 mg IM single injection)
Number of subjects: 236
Study 16330297 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (7.5 mg IM multiple injections)
Number of subjects: 236
Study 16330297 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine (10 mg IM multiple injections)
Number of subjects: 236
Study 12534508 — intervention group
Group type: COMPARATOR
Intervention: 585-nm pulsed dye laser (PDL) alone
Number of subjects: 22
Study 12534508 — intervention group
Group type: EXPERIMENTAL
Intervention: 585-nm pulsed dye laser (PDL) with intralesional corticosteroids
Number of subjects: 22
Study 11140808 — intervention group
Group type: EXPERIMENTAL
Intervention: l-carnitine (20 mg/kg)
Number of subjects: 16
Study 11140808 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 16
Study 8879897 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan (6 mg)
Number of subjects: 158
Study 8879897 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study 1773997 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mobilization in a stabilizing orthosis
Number of subjects: 80
Study 1773997 — intervention group
Group type: COMPARATOR
Intervention: Total immobilization in a walking plaster cast
Number of subjects: 80
Study 6408672 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (1.0 g/kg)
Number of subjects: 16
Study 6408672 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 30526051 — intervention group
Group type: EXPERIMENTAL
Intervention: Brinzolamide-brimonidine fixed combination
Number of subjects: 62
Study 30526051 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 62
Study 30706521 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid distribution timetable
Number of subjects: 24
Study 30706521 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 24
Study 26745962 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-duration tourniquet use
Number of subjects: 50
Study 26745962 — intervention group
Group type: COMPARATOR
Intervention: Short-duration tourniquet use
Number of subjects: 50
Study 26588807 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise test using dry air
Number of subjects: 146
Study 25764777 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard therapy (neurodevelopmental rehabilitation and classic kinesiotherapy) plus botulinum toxin
Number of subjects: 0
Study 25764777 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (neurodevelopmental rehabilitation and classic kinesiotherapy)
Number of subjects: 0
Study 22631564 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (ASAQ)
Number of subjects: 301
Study 22631564 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 301
Study 19651803 — intervention group
Group type: EXPERIMENTAL
Intervention: Glabridin (licorice-root ethanol extract)
Number of subjects: 0
Study 16836903 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of putative periodontal microorganisms in AgP patients using 16S rRNA based PCR
Number of subjects: 72
Study 16836903 — intervention group
Group type: COMPARATOR
Intervention: Detection of putative periodontal microorganisms in healthy controls using 16S rRNA based PCR
Number of subjects: 72
Study 12791117 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus dose alone (BD) - pethidine 0.3 mg.kg‐1 loading dose and 150 micro g.kg‐1 bolus intravenously
Number of subjects: 40
Study 12791117 — intervention group
Group type: COMPARATOR
Intervention: Bolus dose with background infusion (BD + BI) - pethidine 0.3 mg.kg‐1 loading dose, 75 micro g.kg‐1 bolus, and 15 micro g.kg‐1.h‐1 background infusion
Number of subjects: 40
Study 11004355 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical membrane sweeping during induction of labor
Number of subjects: 130
Study 11004355 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical membrane sweeping during induction of labor with oxytocin alone
Number of subjects: 130
Study 8968267 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaspirin cross‐linked hemoglobin solution (100 mg/kg)
Number of subjects: 24
Study 8968267 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaspirin cross‐linked hemoglobin solution (25 mg/kg)
Number of subjects: 24
Study 8968267 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaspirin cross‐linked hemoglobin solution (50 mg/kg)
Number of subjects: 24
Study 8968267 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaspirin cross‐linked hemoglobin solution
Number of subjects: 24
Study 8968267 — intervention group
Group type: COMPARATOR
Intervention: Control (lactated Ringer's solution)
Number of subjects: 24
Study 1298079 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole 400 mg twice daily for two weeks
Number of subjects: 81
Study 1298079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 6734299 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorcainide
Number of subjects: 13
Study 6734299 — intervention group
Group type: COMPARATOR
Intervention: Quinidine
Number of subjects: 13
Study 31216604 — intervention group
Group type: EXPERIMENTAL
Intervention: Tangible support
Number of subjects: 151
Study 29590719 — intervention group
Group type: EXPERIMENTAL
Intervention: Smelling amniotic fluid for 15 minutes before, during, and after peripheral cannulation
Number of subjects: 61
Study 29590719 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 61
Study 26560899 — intervention group
Group type: EXPERIMENTAL
Intervention: PEH-MR 30-mg modified-release tablets every 12 hours for 7 days
Number of subjects: 575
Study 26560899 — intervention group
Group type: COMPARATOR
Intervention: Placebo every 12 hours for 7 days
Number of subjects: 575
Study 26560899 — intervention group
Group type: EXPERIMENTAL
Intervention: PEH-MR 30-mg modified-release tablets
Number of subjects: 575
Study 26560899 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 575
Study 26560899 — intervention group
Group type: EXPERIMENTAL
Intervention: PEH-MR and placebo
Number of subjects: 575
Study 23864363 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) plus standard care
Number of subjects: 26
Study 23864363 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 26
Study 22050410 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone 20-mg
Number of subjects: 20
Study 22050410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 18562023 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary spasm group (ACh testing)
Number of subjects: 33
Study 18562023 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33
Study 18562023 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary spasm group (sublingual nitroglycerin)
Number of subjects: 33
Study 18562023 — intervention group
Group type: COMPARATOR
Intervention: Control group (sublingual nitroglycerin)
Number of subjects: 33
Study 17804953 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Dementia Rating (CDR)
Number of subjects: 343
Study 16175767 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial shock wave therapy (RSWT) - 2000 impulses, 4 weeks treatment
Number of subjects: 62
Study 16175767 — intervention group
Group type: COMPARATOR
Intervention: Control group - 20 impulses of RSWT, 4 weeks treatment
Number of subjects: 62
Study 12391035 — intervention group
Group type: EXPERIMENTAL
Intervention: Running
Number of subjects: 10
Study 12391035 — intervention group
Group type: COMPARATOR
Intervention: Cycling
Number of subjects: 10
Study 10713581 — intervention group
Group type: EXPERIMENTAL
Intervention: 10‐item Abbreviated Mental Test (AMT)
Number of subjects: 246
Study 10713581 — intervention group
Group type: EXPERIMENTAL
Intervention: 18‐item Chinese Mini‐Mental Status Examination (CMMSE)
Number of subjects: 246
Study 10713581 — intervention group
Group type: COMPARATOR
Intervention: AMT and CMMSE
Number of subjects: 246
Study 8691224 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery revascularization
Number of subjects: 0
Study 8691224 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0
Study 1736698 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural butorphanol 2 mg
Number of subjects: 45
Study 1736698 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous butorphanol 2 mg
Number of subjects: 45
Study 1736698 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 45
Study 6386593 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 500 mg intravenous infusion
Number of subjects: 219
Study 6386593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study 31262348 — intervention group
Group type: EXPERIMENTAL
Intervention: Fimasartan
Number of subjects: 119
Study 31262348 — intervention group
Group type: COMPARATOR
Intervention: Perindopril
Number of subjects: 119
Study 29966801 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured nurse-coordinated intensive intervention program (9 one-to-one sessions over a mean period of 5 years)
Number of subjects: 0
Study 29966801 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study 29966801 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured nurse-coordinated intensive intervention program
Number of subjects: 0
Study 27378545 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent present during dental treatment
Number of subjects: 100
Study 27378545 — intervention group
Group type: COMPARATOR
Intervention: Parent absent during dental treatment
Number of subjects: 100
Study 27378545 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's perception of their treatment
Number of subjects: 100
Study 25192777 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT)
Number of subjects: 14
Study 25192777 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Moderate-Intensity Training (CMT)
Number of subjects: 14
Study 22402934 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise training (SET) for PAD patients, duration of 3 weeks and 12 weeks, specific details on dosage not applicable.
Number of subjects: 22
Study 22402934 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 control subjects), no intervention reported.
Number of subjects: 22
Study 19201066 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over left primary motor cortex (M1)
Number of subjects: 0
Study 19201066 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 17388747 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol turbuhaler (FT) 9 mug
Number of subjects: 17
Study 17388747 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol diskus (SD) 200 mug
Number of subjects: 17
Study 17388747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 16139699 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching adhesive system Adper Prompt L-Pop applied for 15 s after 60 s etching of enamel and 20 s etching of dentin
Number of subjects: 40
Study 16139699 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching adhesive system Adper Prompt L-Pop applied for 15 s
Number of subjects: 40
Study 16139699 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching adhesive system Adper Prompt L-Pop applied for 30 s
Number of subjects: 40
Study 16139699 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching adhesive system Adper Prompt L-Pop applied for 45 s
Number of subjects: 40
Study 16139699 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching adhesive system Adper Prompt L-Pop applied for 15, 30, and 45 s without pre-etching
Number of subjects: 40
Study 12494049 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg t.i.d.)
Number of subjects: 88
Study 12494049 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg o.d.)
Number of subjects: 88
Study 12494049 — intervention group
Group type: COMPARATOR
Intervention: Control group (no calcium antagonists)
Number of subjects: 88
Study 10529464 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg/day)
Number of subjects: 30
Study 10529464 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 7777113 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum transaminases (ST) levels in hemodialysis patients
Number of subjects: 217
Study 7777113 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic (ROC) analysis for ST
Number of subjects: 217
Study 7777113 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 217
Study 2323650 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction and consolidation chemotherapy with weekly parenteral vincristine, Adriamycin, l-asparaginase and daily oral prednisone (VAAP), followed by standard CNS prophylaxis. Maintenance therapy for 3 years with daily 6-mercaptopurine, weekly methotrexate and monthly intrathecal therapy, with drug intensification comprising either vincristine, Adriamycin and l-asparaginase (VAA) or cyclophosphamide, vincristine, cytosine arabinoside and prednisone (COAP).
Number of subjects: 85
Study 389512 — intervention group
Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 10
Study 389512 — intervention group
Group type: EXPERIMENTAL
Intervention: Procaineamide
Number of subjects: 10
Study 389512 — intervention group
Group type: EXPERIMENTAL
Intervention: Disopyramide
Number of subjects: 10
Study 31814419 — intervention group
Group type: EXPERIMENTAL
Intervention: Music training (improvisation exercises)
Number of subjects: 45
Study 31814419 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music training)
Number of subjects: 45
Study 31892758 — intervention group
Group type: EXPERIMENTAL
Intervention: AHP disinfectant wipes
Number of subjects: 30
Study 31892758 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol disinfectant wipes
Number of subjects: 30
Study 31892758 — intervention group
Group type: EXPERIMENTAL
Intervention: QAC disinfectant wipes
Number of subjects: 30
Study 31892758 — intervention group
Group type: COMPARATOR
Intervention: Untreated (NT) keyboards
Number of subjects: 30
Study 28709776 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 241
Study 28709776 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 241
Study 28709776 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 241
Study 28709776 — intervention group
Group type: COMPARATOR
Intervention: Aripiprazole
Number of subjects: 241
Study 27217453 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin-releasing hormone agonist (GnRHa) plus norethisterone
Number of subjects: 129
Study 27217453 — intervention group
Group type: COMPARATOR
Intervention: Norethisterone alone (control group)
Number of subjects: 129
Study 26711437 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ml single use dropper bottle
Number of subjects: 204
Study 26711437 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g single application squeeze tube containing gel
Number of subjects: 204
Study 26711437 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 ml bottle with cotton swab
Number of subjects: 204
Study 23244045 — intervention group
Group type: EXPERIMENTAL
Intervention: Retro-cued items
Number of subjects: 0
Study 23244045 — intervention group
Group type: COMPARATOR
Intervention: Uncued objects
Number of subjects: 0
Study 23244045 — intervention group
Group type: EXPERIMENTAL
Intervention: Color retro-cues
Number of subjects: 0
Study 19408119 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Simultaneous Medical Interpreting (RSMI)
Number of subjects: 782
Study 19408119 — intervention group
Group type: COMPARATOR
Intervention: Usual and Customary (U&C) interpreting
Number of subjects: 782
Study 19408119 — intervention group
Group type: EXPERIMENTAL
Intervention: BDI-FS positive patients (overall)
Number of subjects: 782
Study 19408119 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese speakers among BDI-FS positive patients
Number of subjects: 782
Study 19040739 — intervention group
Group type: EXPERIMENTAL
Intervention: Ilioinguinal-iliohypogastric nerve block (IINB) with 0.5% bupivacaine + 5 mcg/ml epinephrine (Group I, n = 28)
Number of subjects: 60
Study 19040739 — intervention group
Group type: COMPARATOR
Intervention: Saline control (Group II, n = 32)
Number of subjects: 60
Study 19040739 — intervention group
Group type: EXPERIMENTAL
Intervention: Ilioinguinal-iliohypogastric nerve block (IINB) (Group I)
Number of subjects: 60
Study 19040739 — intervention group
Group type: COMPARATOR
Intervention: Saline control (Group II)
Number of subjects: 60
Study 16172569 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc‐EDDA‐hydrazinonicotinyl‐Tyr3‐octreotide (Tc‐TOC)
Number of subjects: 88
Study 16172569 — intervention group
Group type: EXPERIMENTAL
Intervention: SPECT imaging
Number of subjects: 88
Study 14656279 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 172
Study 14656279 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 172
Study 14656279 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 172
Study 10847421 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin (50, 100, and 200 U/kg)
Number of subjects: 6
Study 10847421 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (0.5, 1.0, and 2.0 mg/kg)
Number of subjects: 6
Study 10847421 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin and Enoxaparin (therapeutic equivalent doses)
Number of subjects: 6
Study 9029666 — intervention group
Group type: EXPERIMENTAL
Intervention: Amineptine
Number of subjects: 22
Study 9029666 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 1825799 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine (administered according to two schedules: early at birth, 3 months, and 6 months; later at 3 months, 4.5 months, and 6 months)
Number of subjects: 1989
Study 1825799 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine (unscheduled administration)
Number of subjects: 1989
Study 1825799 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine
Number of subjects: 1989
Study 1825799 — intervention group
Group type: COMPARATOR
Intervention: Poliomyelitis vaccine
Number of subjects: 1989
Study 6299161 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass closure technique
Number of subjects: 1129
Study 6299161 — intervention group
Group type: COMPARATOR
Intervention: Polyglycolic acid
Number of subjects: 1129
Study 6299161 — intervention group
Group type: COMPARATOR
Intervention: Monofilament nylon
Number of subjects: 1129
Study 31074022 — intervention group
Group type: EXPERIMENTAL
Intervention: Random forest classifier model using top 50 important radiomics features
Number of subjects: 118
Study 28791447 — intervention group
Group type: EXPERIMENTAL
Intervention: Active pulsed magnetic stimulation (PMS)
Number of subjects: 120
Study 28791447 — intervention group
Group type: COMPARATOR
Intervention: Sham pulsed magnetic stimulation
Number of subjects: 120
Study 28791447 — intervention group
Group type: COMPARATOR
Intervention: No active pulsed magnetic stimulation
Number of subjects: 120
Study 27418815 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrronium (GLY) 50 μg
Number of subjects: 126
Study 27418815 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium (TIO) 18 μg
Number of subjects: 126